Rezolve Ai criticizes Commerce.com poison pill adoption
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Rezolve Ai Slams Commerce.com Board’s "Desperate" Poison Pill That Will Dilute Shareholders and Stagnate Growth Further
April 14, 2026 1:32 PM EDTLabels Tactic a "White Flag" Following Prolonged Equity Collapse and No Clear Recovery Plan
Calls Into Question Boards Competence Ahead of May 14 Election
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai PLC (NASDAQ: RZLV), a global leader in AI-powered commerce, today responded to the Commerce.com, Inc. (Nasdaq: CMRC) Board of Directors adoption of a stockholder rights plan (Poison Pill or Rights Plan).
Rezolve Ai views this as a transparent attempt by a failing Board to entrench itself and prevent... More
